Skip to main content
. 2020 Dec 13;4(2):174–192. doi: 10.1002/tsm2.215

Table 2.

Significant metabolites identified through linear regression to BMI for both volunteer's 1H‐NMR and UPLC‐MS urinary datasets

Metabolite 1H‐NMR urinary metabolites
BMI association Chemical shift, PPM (multiplicity)* P‐value
N‐methyl nicotinate 4.44 (s), 8.09 (t), 8.84 (t), 9.13 (s) .000527
Hippurate 3.98 (d), 7.54 (t), 7.65 (t), 7.84 (d) .0322
Phenylacetylglutamine 1.92 (m), 2.11 (m), 2.27 (m), 3.67 (m), 4.19 (m), 7.36 (t), 7.43 (t) .0154
Metabolite UPLC‐MS urinary metabolites
BMI association Molecular weight P‐value
L‐Serine 355.2 .00655
L‐Asparagine 382.2 .0131
L‐Isoleucine 381.19 .00726
D‐2‐aminobutyric acid 353.23 .0489

N‐methyl nicotinate (NMNA) and hippurate were shown to be positively correlated with BMI while phenylacetylglutamine (PAG) demonstrated inverse correlation with BMI. All significant UPLC‐MS metabolites were negatively correlated with BMI. For 1H‐NMR profiles, chemical shifts of each metabolite, and their corresponding multiplicity were used in the identification process. A significant P‐value threshold of .05 was chosen after calculating the false discovery rate (FDR).

*Multiplicity: s, singlet; d, doublet; t, triplet; m, multiplet.